Cargando…

In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology

Injectable bone substitutes (IBS) are increasingly being used in the fields of orthopedics and maxillofacial/oral surgery. The rheological properties of IBS allow for proper and less invasive filling of bony defects. Vaterite is the most unstable crystalline polymorph of calcium carbonate and is kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Unger, Ronald E., Stojanovic, Sanja, Besch, Laura, Alkildani, Said, Schröder, Romina, Jung, Ole, Bogram, Caroline, Görke, Oliver, Najman, Stevo, Tremel, Wolfgang, Barbeck, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835873/
https://www.ncbi.nlm.nih.gov/pubmed/35163120
http://dx.doi.org/10.3390/ijms23031196
_version_ 1784649539376906240
author Unger, Ronald E.
Stojanovic, Sanja
Besch, Laura
Alkildani, Said
Schröder, Romina
Jung, Ole
Bogram, Caroline
Görke, Oliver
Najman, Stevo
Tremel, Wolfgang
Barbeck, Mike
author_facet Unger, Ronald E.
Stojanovic, Sanja
Besch, Laura
Alkildani, Said
Schröder, Romina
Jung, Ole
Bogram, Caroline
Görke, Oliver
Najman, Stevo
Tremel, Wolfgang
Barbeck, Mike
author_sort Unger, Ronald E.
collection PubMed
description Injectable bone substitutes (IBS) are increasingly being used in the fields of orthopedics and maxillofacial/oral surgery. The rheological properties of IBS allow for proper and less invasive filling of bony defects. Vaterite is the most unstable crystalline polymorph of calcium carbonate and is known to be able to transform into hydroxyapatite upon contact with an organic fluid (e.g., interstitial body fluid). Two different concentrations of hydrogels based on poly(ethylene glycol)-acetal-dimethacrylat (PEG-a-DMA), i.e., 8% (w/v) (VH-A) or 10% (w/v) (VH-B), were combined with vaterite nanoparticles and implanted in subcutaneous pockets of BALB/c mice for 15 and 30 days. Explants were prepared for histochemical staining and immunohistochemical detection methods to determine macrophage polarization, and energy-dispersive X-ray analysis (EDX) to analyze elemental composition was used for the analysis. The histopathological analysis revealed a comparable moderate tissue reaction to the hydrogels mainly involving macrophages. Moreover, the hydrogels underwent a slow cellular infiltration, revealing a different degradation behavior compared to other IBS. The immunohistochemical detection showed that M1 macrophages were mainly found at the material surfaces being involved in the cell-mediated degradation and tissue integration, while M2 macrophages were predominantly found within the reactive connective tissue. Furthermore, the histomorphometrical analysis revealed balanced numbers of pro- and anti-inflammatory macrophages, demonstrating that both hydrogels are favorable materials for bone tissue regeneration. Finally, the EDX analysis showed a stepwise transformation of the vaterite particle into hydroxyapatite. Overall, the results of the present study demonstrate that hydrogels including nano-vaterite particles are biocompatible and suitable for bone tissue regeneration applications.
format Online
Article
Text
id pubmed-8835873
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88358732022-02-12 In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology Unger, Ronald E. Stojanovic, Sanja Besch, Laura Alkildani, Said Schröder, Romina Jung, Ole Bogram, Caroline Görke, Oliver Najman, Stevo Tremel, Wolfgang Barbeck, Mike Int J Mol Sci Article Injectable bone substitutes (IBS) are increasingly being used in the fields of orthopedics and maxillofacial/oral surgery. The rheological properties of IBS allow for proper and less invasive filling of bony defects. Vaterite is the most unstable crystalline polymorph of calcium carbonate and is known to be able to transform into hydroxyapatite upon contact with an organic fluid (e.g., interstitial body fluid). Two different concentrations of hydrogels based on poly(ethylene glycol)-acetal-dimethacrylat (PEG-a-DMA), i.e., 8% (w/v) (VH-A) or 10% (w/v) (VH-B), were combined with vaterite nanoparticles and implanted in subcutaneous pockets of BALB/c mice for 15 and 30 days. Explants were prepared for histochemical staining and immunohistochemical detection methods to determine macrophage polarization, and energy-dispersive X-ray analysis (EDX) to analyze elemental composition was used for the analysis. The histopathological analysis revealed a comparable moderate tissue reaction to the hydrogels mainly involving macrophages. Moreover, the hydrogels underwent a slow cellular infiltration, revealing a different degradation behavior compared to other IBS. The immunohistochemical detection showed that M1 macrophages were mainly found at the material surfaces being involved in the cell-mediated degradation and tissue integration, while M2 macrophages were predominantly found within the reactive connective tissue. Furthermore, the histomorphometrical analysis revealed balanced numbers of pro- and anti-inflammatory macrophages, demonstrating that both hydrogels are favorable materials for bone tissue regeneration. Finally, the EDX analysis showed a stepwise transformation of the vaterite particle into hydroxyapatite. Overall, the results of the present study demonstrate that hydrogels including nano-vaterite particles are biocompatible and suitable for bone tissue regeneration applications. MDPI 2022-01-21 /pmc/articles/PMC8835873/ /pubmed/35163120 http://dx.doi.org/10.3390/ijms23031196 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Unger, Ronald E.
Stojanovic, Sanja
Besch, Laura
Alkildani, Said
Schröder, Romina
Jung, Ole
Bogram, Caroline
Görke, Oliver
Najman, Stevo
Tremel, Wolfgang
Barbeck, Mike
In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
title In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
title_full In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
title_fullStr In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
title_full_unstemmed In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
title_short In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
title_sort in vivo biocompatibility investigation of an injectable calcium carbonate (vaterite) as a bone substitute including compositional analysis via sem-edx technology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835873/
https://www.ncbi.nlm.nih.gov/pubmed/35163120
http://dx.doi.org/10.3390/ijms23031196
work_keys_str_mv AT ungerronalde invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT stojanovicsanja invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT beschlaura invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT alkildanisaid invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT schroderromina invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT jungole invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT bogramcaroline invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT gorkeoliver invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT najmanstevo invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT tremelwolfgang invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology
AT barbeckmike invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology